ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,359Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 337

$383K Total Retail Price of All Prescriptions

Rank: 118 out of 337

413 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 413 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 413 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 7,910 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
AMLODIPINE BESYLATE 493 467 1 3
LISINOPRIL 473 403 2 2
SIMVASTATIN 407 358 3 1
LEVOTHYROXINE SODIUM 375 305 4 5
ATENOLOL 354 324 5 10
OMEPRAZOLE 338 281 6 4
ATORVASTATIN CALCIUM 295 247 7 7
HYDROCHLOROTHIAZIDE 286 250 8 9
FUROSEMIDE 250 225 9 8
METOPROLOL TARTRATE 219 199 10 6
LOSARTAN POTASSIUM 198 186 11 15
LOVASTATIN 186 174 12 24
PAROXETINE HCL 155 141 13 46
ALENDRONATE SODIUM 152 127 14 19
CITALOPRAM HBR 151 135 15 17
METFORMIN HCL 129 81 16 12
ZOLPIDEM TARTRATE 128 105 17 23
GLIPIZIDE 126 112 18 45
METOPROLOL SUCCINATE 124 117 19 21
FLUTICASONE PROPIONATE 108 72 20 34
ENALAPRIL MALEATE 93 80 21 37
TRIAMTERENE-HCTZ 91 91 22 39
TRAMADOL HCL 86 80 23 32
GABAPENTIN 83 70 24 20
TRAZODONE HCL 81 71 25 16
LIPITOR 79 66 26 33
QUINAPRIL HCL 76 76 27 50
PRAVASTATIN SODIUM 76 63 27 14
DONEPEZIL HCL 74 74 29 22
WARFARIN SODIUM 74 65 29 11
LANTUS 65 38 31 49
GLIPIZIDE ER 56 56 32 69
RANITIDINE HCL 56 29 32 30
CYCLOBENZAPRINE HCL 52 12 R 34 103
FELODIPINE ER 50 50 35 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.